Market Cap 35.06B
Revenue (ttm) 10.38B
Net Income (ttm) 1.00M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 19.38
Profit Margin 0.01%
Debt to Equity Ratio 0.59
Volume 24,500
Avg Vol 26,342
Day's Range N/A - N/A
Shares Out 440.00M
Stochastic %K 100%
Beta 0.52
Analysts Sell
Price Target $82.30

Company Profile

Sandoz Group AG develops, manufactures, and markets generic and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, supportive care, rare diseases, diabetes, immunology, endocrinology, neurology, osteoporosis, nephrology, hematology, and ophthalmology. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. Sandoz Group AG was founded in 1886 and is...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 41 61 324 11 11
Address:
Centralbahnstrasse 4, Basel, Switzerland
Latest News on SDZNY
No data available.